BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26818702)

  • 21. Antitumor and antiparasitic activity of novel ruthenium compounds with polycyclic aromatic ligands.
    Miserachs HG; Cipriani M; Grau J; Vilaseca M; Lorenzo J; Medeiros A; Comini MA; Gambino D; Otero L; Moreno V
    J Inorg Biochem; 2015 Sep; 150():38-47. PubMed ID: 26079954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA Binding Behavior, Sensor Studies, Antimicrobial, Photocleavage and In vitro Cytotoxicity of Synthesized Ru(II) Complexes with Assorted Intercalating Polypyridyl Ligands.
    Mallepally RR; Putta VR; Chintakuntla N; Vuradi RK; Kotha LR; Sirasani S
    J Fluoresc; 2016 May; 26(3):1101-13. PubMed ID: 27067208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
    Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
    J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luminescent ruthenium polypyridyl complexes with extended 'dppz' like ligands as DNA targeting binders and cellular agents.
    Poulsen BC; Estalayo-Adrián S; Blasco S; Bright SA; Kelly JM; Williams DC; Gunnlaugsson T
    Dalton Trans; 2016 Nov; 45(45):18208-18220. PubMed ID: 27796397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle, apoptosis, cellular uptake and whole-transcriptome microarray gene expression analysis of HeLa cells treated with a ruthenium(II)-arene complex with an isoquinoline-3-carboxylic acid ligand.
    Jovanović KK; Tanić M; Ivanović I; Gligorijević N; Dojčinović BP; Radulović S
    J Inorg Biochem; 2016 Oct; 163():362-373. PubMed ID: 27118029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.
    Filak LK; Mühlgassner G; Jakupec MA; Heffeter P; Berger W; Arion VB; Keppler BK
    J Biol Inorg Chem; 2010 Aug; 15(6):903-18. PubMed ID: 20369265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
    Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
    J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
    Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
    J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metal complexes as DNA intercalators.
    Liu HK; Sadler PJ
    Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half-sandwich RuCl2(η(6)-p-cymene) core complexes containing sulfur donor aroylthiourea ligands: DNA and protein binding, DNA cleavage and cytotoxic studies.
    Jeyalakshmi K; Haribabu J; Bhuvanesh NS; Karvembu R
    Dalton Trans; 2016 Aug; 45(31):12518-31. PubMed ID: 27435011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands.
    Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG
    Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex.
    Brabec V; Pracharova J; Stepankova J; Sadler PJ; Kasparkova J
    J Inorg Biochem; 2016 Jul; 160():149-55. PubMed ID: 26778426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual topoisomerase I and II poisoning by chiral Ru(II) complexes containing 2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives.
    Wang YC; Qian C; Peng ZL; Hou XJ; Wang LL; Chao H; Ji LN
    J Inorg Biochem; 2014 Jan; 130():15-27. PubMed ID: 24145066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
    Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
    Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
    Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
    J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.
    Kumar YP; Devi CS; Srishailam A; Deepika N; Kumar VR; Reddy PV; Nagasuryaprasad K; Singh SS; Nagababu P; Satyanarayana S
    J Fluoresc; 2016 Nov; 26(6):2119-2132. PubMed ID: 27589976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ruthenium(II) polypyridyl complexes: synthesis and studies of DNA binding, photocleavage, cytotoxicity, apoptosis, cellular uptake, and antioxidant activity.
    Liu YJ; Liang ZH; Li ZZ; Yao JH; Huang HL
    DNA Cell Biol; 2011 Oct; 30(10):829-38. PubMed ID: 21395447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and DNA binding properties of ruthenium(II) complexes containing the redox active ligand benzo[i]dipyrido[3,2-a:2',3'-c]phenazine-11,16-quinone.
    Foxon SP; Green C; Walker MG; Wragg A; Adams H; Weinstein JA; Parker SC; Meijer AJ; Thomas JA
    Inorg Chem; 2012 Jan; 51(1):463-71. PubMed ID: 22145812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.